Skip to content
GCMI Atlanta – Pre Clinical CRO
Successfully guiding medtech innovation
GCMI Atlanta - Pre Clinical CROGCMI Atlanta - Pre Clinical CRO
  • About GCMI
    • Our Work
    • Why GCMI?
    • Leadership
  • Services
    • Lifecycle Advisory
    • Design and Development
      • Early Stage Product Design
      • Design History File Generation
      • Clinical Input and Review
      • Project Management
      • Biomedical and Mechanical Engineering
    • Preclinical Testing Services
      • Cardiovascular
      • Drugs and Biologics
      • Orthopedic
      • General / Urology / GI
      • Regenerative Medicine and Wound Healing
      • Animal Models
      • Preclinical Pathology
      • Preclinical Consulting Services
    • Bioskills Training
    • Accelerator
    • Incubator
  • Facilities
    • Preclinical Testing and Bioskills Training Facilities
    • Design and Development Facilities
  • Quality and Compliance
  • Blog and News
  • Contact Us
Twitter page opens in new windowLinkedin page opens in new window
Search:
Search
  • About GCMI
    • Our Work
    • Why GCMI?
    • Leadership
  • Services
    • Lifecycle Advisory
    • Design and Development
      • Early Stage Product Design
      • Design History File Generation
      • Clinical Input and Review
      • Project Management
      • Biomedical and Mechanical Engineering
    • Preclinical Testing Services
      • Cardiovascular
      • Drugs and Biologics
      • Orthopedic
      • General / Urology / GI
      • Regenerative Medicine and Wound Healing
      • Animal Models
      • Preclinical Pathology
      • Preclinical Consulting Services
    • Bioskills Training
    • Accelerator
    • Incubator
  • Facilities
    • Preclinical Testing and Bioskills Training Facilities
    • Design and Development Facilities
  • Quality and Compliance
  • Blog and News
  • Contact Us

Tag Archives: interventional radiology

Surefire Precision gains FDA 510(k) clearance twice as fast as the industry average with T3 Labs

Medical device testing case studies, News, Preclinical CRO Excellence, T3By PaulSeptember 24, 2015

Surefire Medical achieves FDA 510(k) clearance for direct-to-tumor embolization device Surefire Precision in just 76 days with the help of T3 Labs.

Go to Top